Placeholder

Developing A True Strategic Partnership

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

The biopharmaceutical industry is facing intense pressure within research and development to bring new drugs to the market at a time when drug development has become complex and expensive. Blockbuster patent expirations, more complex protocols, increasing R&D costs, patient recruitment issues, and more stringent regulatory and safety issues are all challenging drug developers.
As a result, pharmaceutical and biotech companies are beginning to rethink their approach to outsourcing and how best to build alliances with external service providers, according to a panel of industry leaders recently convened…

Sidebar:
Tips for Creating Strategic ­Partnerships
Sound bites From the Field

Edward J. Brennan, M.D., is President and CEO, IndiPharm Inc., a clinical research organization (CRO) providing the full range of clinical trial services. For more information, visit indipharm.com.
Graham Bunn is VP, Partnerships and Alliances, Medidata Solutions, a global provider of SaaS-based clinical development solutions. For more information, visit mdsol.com.
Kristan Gallitano is VP of Data Management Solutions at eClinical
Solutions, a division of Eliassen Group, and a clinical data management consulting firm. For more information, visit eclinicalsol.com.
Randy Kehrmeyer is President of Kforce Clinical Research, a professional staffing and solutions firm. For more information, visit kforce.com.
JF Marier, Ph.D., is VP and Lead Scientist, at Pharsight, a Certara company, a provider of software products and
scientific consulting services to facilitate improved productivity and strategic decision making in drug development. For more information, visit pharsight.com.
Michael Soenen is President and CEO, ClearTrial, a provider of clinical trial operations (CTO) software. For more
information, visit cleartrial.com.
Rising Trial Complexity Continues to Vex Drug Developers

Experts
Vince Aurentz. Head of Customer ­Solutions, Quintiles, a services company ­offering clinical, commercial, consulting, and capital solutions worldwide. For more information, visit quintiles.com.
Tim Dietlin. VP of Alliance Development, INC Research, a therapeutically focused contract research organization. For more information, visit incresearch.com.
Mark A. Goldberg, M.D. Chief Operating Officer, Parexel International, a global services organization that provides the right level of guidance to bring safe and effective treatments to patients sooner. For more information, visit parexel.com.
Raymond Panas. Director of ­International Clinical Development, ­Sucampo Pharmaceuticals, which is focused on the development of medicines based on prostones. For more information, visit sucampo.com.
Julian Remnant. R&D Advisory Lead Partner (Europe), Consulting, Deloitte, which offers professional services that cut across all ­segments of the healthcare and life-sciences industry. For more information, visit deloitte.com.
Mark Roseman. Senior VP, Sales and Chief ­Marketing Officer, Kendle, a global clinical research ­organization providing a full range of early- to ­late-stage clinical development services. For more ­information, visit kendle.com.
Aize Smink. Executive VP, Global Clinical Development, Chiltern, a global contract research organization with experience
conducting Phase I to Phase IV ­clinical trials. For more information, visit chiltern.com.
Colin Terry. Executive VP, Commercial Operations, Aptuit, an integrated services ­company that provides drug development and drug discovery solutions. For more information, visit ­aptuit.com.
Gene Wright. Senior VP, Clinical Development, Zalicus Inc., a company that ­discovers and develops novel treatments for pain and immuno-inflammatory ­diseases. For more information, visit zalicus.com.

FEEDBACK